Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Adjuvant chemotherapy for non-small-cell lung cancer--the smoke clears.

× No keyword cloud information.

10 in total

1. Quality-of-life outcomes for adjuvant chemotherapy in early-stage non-small-cell lung cancer: results from a randomized trial, JBR.10.

Authors: Andrea Bezjak; Christopher W Lee; Keyue Ding; Michael Brundage; Timothy Winton; Barbara Graham; Marlo Whitehead; David H Johnson; Robert B Livingston; Lesley Seymour; Frances A Shepherd
Journal: J Clin Oncol Date: 2008-09-22 Impact factor: 44.544

2. Clinical efficacy of percutaneous cryoablation combined with allogenic NK cell immunotherapy for advanced non-small cell lung cancer.

Authors: Mao Lin; Shu-Zhen Liang; Xiao-Hua Wang; Ying-Qing Liang; Ming-Jie Zhang; Li-Zhi Niu; Ji-Bing Chen; Hai-Bo Li; Ke-Cheng Xu
Journal: Immunol Res Date: 2017-08 Impact factor: 2.829

3. Pembrolizumab plus allogeneic NK cells in advanced non-small cell lung cancer patients.

Authors: Mao Lin; Haihua Luo; Shuzhen Liang; Jibing Chen; Aihua Liu; Lizhi Niu; Yong Jiang
Journal: J Clin Invest Date: 2020-05-01 Impact factor: 14.808

4. Using circulating tumor cells to evaluate the efficacy of irreversible electroporation for unresectasble pancreatic cancer.

Authors: Mao Lin; Mohammed Alnaggar; Shu-Zhen Liang; Jian Shi; Li-Zhi Niu; Ji-Bing Chen; Ke-Cheng Xu
Journal: Immunol Res Date: 2018-02 Impact factor: 2.829

5. Percutaneous irreversible electroporation combined with allogeneic natural killer cell immunotherapy for patients with unresectable (stage III/IV) pancreatic cancer: a promising treatment.

Authors: Mao Lin; Shuzhen Liang; Xiaohua Wang; Yinqing Liang; Mingjie Zhang; Jibing Chen; Lizhi Niu; Kecheng Xu
Journal: J Cancer Res Clin Oncol Date: 2017-09-04 Impact factor: 4.553

6. Survival after surgery in stage IA and IB non-small cell lung cancer.

Authors: David Ost; Judith Goldberg; Linda Rolnitzky; William N Rom
Journal: Am J Respir Crit Care Med Date: 2007-11-15 Impact factor: 21.405

7. Adjuvant cellular immunotherapy in patients with resected primary non-small cell lung cancer.

Authors: Qiu-Zhong Pan; Yan Tang; Qi-Jing Wang; Yong-Qiang Li; Li Zhang; Xiao-Dong Li; Jing-Jing Zhao; De-Sheng Weng; Qing Liu; Li-Xi Huang; Jia He; Shi-Ping Chen; Miao-La Ke; Yi-Xin Zeng; Jian-Chuan Xia
Journal: Oncoimmunology Date: 2015-05-27 Impact factor: 8.110

8. An important discovery on combination of irreversible electroporation and allogeneic natural killer cell immunotherapy for unresectable pancreatic cancer.

Authors: Mao Lin; Mohammed Alnaggar; Shuzhen Liang; Xiaohua Wang; Yinqing Liang; Mingjie Zhang; Jibing Chen; Lizhi Niu; Kecheng Xu
Journal: Oncotarget Date: 2017-10-19

9. Clinical features and prognosis according to genomic mutations in primary and metastatic lesions of non-small-cell lung cancer.

Authors: Wei Zhang; Wenjuan Han; Bo Yu; Xin Zhao; Gaojun Lu; Wendy Wu; Yi Zhang
Journal: Thorac Cancer Date: 2022-04-24 Impact factor: 3.223

10. Effects of a gemcitabine plus platinum regimen combined with a dendritic cell-cytokine induced killer immunotherapy on recurrence and survival rate of non-small cell lung cancer patients.

Authors: Min Zhao; Hongbing Li; Lei Li; Yijie Zhang
Journal: Exp Ther Med Date: 2014-02-21 Impact factor: 2.447

10 in total